Direct and oversee regulatory submission strategy at the study level for Pi Health-run studies, aligning submission pathways and timelines with client sponsors and internal cross-functional teams, while personally executing submission-critical content and deliverables as needed
Lead the preparation, compilation, and submission of original Investigational New Drug (IND) applications to the US FDA, including pre-IND interactions, and manage the full lifecycle of IND amendments and annual reporting submissions
Lead CTIMP submissions in the United Kingdom through the Integrated Research Application System (IRAS), including initial applications and substantial modifications, in coordination with the HRA, MHRA, and Research Ethics Committees
Lead CTA submissions in the European Union through the Clinical Trials Information System (CTIS) under the Clinical Trials Regulation (CTR) (EU) No 536/2014, including initial applications, additional Member State submissions, and substantial modifications
Support Clinical Trial Notification (CTN) submissions and Human Research Ethics Committee (HREC) submissions in Australia as program needs require, and coordinate global regulatory submissions in other regions as needed
Assess regulatory requirements across multiple global jurisdictions (FDA, MHRA, EMA, TGA, Health Canada, and others) and provide strategic guidance on regulatory risks, opportunities, and mitigation approaches
Maintain current regulatory intelligence on evolving guidance, regulations, and agency best practices, and communicate the business impact of changes to program teams and clients